Donanemab in Early Alzheimer's Disease.

Mark A. Mintun,Albert C. Lo,Cynthia Duggan Evans,Alette M. Wessels,Paul A. Ardayfio,Scott W. Andersen,Sergey Shcherbinin,JonDavid Sparks,John R. Sims,Mirosław Bryś,Liana G. Apostolova,Stephen Salloway,Daniel M Skovronsky

Donanemab in Early Alzheimer's Disease.

2021

Mark A. Mintun
Albert C. Lo
Cynthia Duggan Evans
Alette M. Wessels
Paul A. Ardayfio
Scott W. Andersen
Sergey Shcherbinin
JonDavid Sparks
John R. Sims
Mirosław Bryś
Liana G. Apostolova
Stephen Salloway
Daniel M Skovronsky

Abstract Background A hallmark of Alzheimer’s disease is the accumulation of amyloid-β (Aβ) peptide. Donanemab, an antibody that targets a modified form of deposited Aβ, is being investigated for t...

Keywords:

Peptide
Medicine
Immunology
Disease
Antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations